menu
    • menu

    Company profile for Intellia Therapeutics

    NEW Drugs in Dev: 10
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing ...
    Many of us pursuing work in the biotechnology industry are inspired by someone in our community who is living with a disease or the loss of a loved one. We know that rare and genetic diseases not only affect the people living with often debilitating and life-threatening symptoms, but that these disorders also significantly impact their families, friends and caregivers. Since the emergence of the breakthrough genome editing technology CRISPR/Cas9, the science has moved fast in only a few years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intellia TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    40 Erie Street, Cambridge, MA 02139
    Telephone
    Telephone
    857-285-6200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intelliatx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intellia Therapeutics Reports Nasdaq Listing Rule 5635(c)(4)
    Intellia Therapeutics Reports Nasdaq Listing Rule 5635(c)(4)

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3251301/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    FDA Fully Releases Clinical Hold On Intellia CRISPR Trials
    FDA Fully Releases Clinical Hold On Intellia CRISPR Trials

    03 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/fda-fully-releases-clinical-hold-intellia-crispr-gene-therapy-trials

    FIERCE BIOTECH
    03 Mar 2026
    Share Share
    Intellia Therapeutics Unveils Lonvo-Z Data for HAE At AAAAI 2026
    Intellia Therapeutics Unveils Lonvo-Z Data for HAE At AAAAI 2026

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248214/0/en/Intellia-Therapeutics-Presents-Longer-Term-Clinical-Data-for-Lonvoguran-Ziclumeran-lonvo-z-Hereditary-Angioedema-HAE-Patient-Focused-Research-at-AAAAI-2026.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Intellia Therapeutics Joins Investor Conferences
    Intellia Therapeutics Joins Investor Conferences

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243528/0/en/Intellia-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Intellia Therapeutics To Discuss Q4 2025 Financials & Business
    Intellia Therapeutics To Discuss Q4 2025 Financials & Business

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240983/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Intellia Therapeutics Discloses Inducement Grants Per Nasdaq Lr
    Intellia Therapeutics Discloses Inducement Grants Per Nasdaq Lr

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233747/0/en/Intellia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search